Tuesday, 8 November 2022

Novavax posts third quarter loss but beats revenue expectations

The Covid-19 vaccine maker reported a net loss of more than $169 million for the third quarter, compared to a loss of $322 million in the same period last year.

from Earnings https://ift.tt/r638eW9
via IFTTT

No comments:

Post a Comment